Kerala runs circles around other states in everything from its literacy rate and infant survival to its sex ratio, the highest in the country. Childbirth there is also the safest in India, with the lowest maternal mortality rate of any state.

There’s another indicator where it is near the top: how few children its women have. Registered births there fell by a third between 2015 and 2024, according to the Civil Registration System’s vital-statistics reportOffice of the Registrar General & Census Commissioner, India (ORGI)REPORT ON VITAL STATISTICS OF INDIA BASED ON THE CIVIL REGISTRATION SYSTEM-2024.

That makes Kerala catnip for in-vitro fertilisation (IVF) chains. Fewer babies don’t mean more infertility, but the reasons behind them push more couples towards fertility clinics. Kerala’s women marry laterOnmanoramaHappily unmarried: 1 in 5 Kerala women single, mean age for wedding touches 25 in a decade than almost anywhere else in India. Many work, often abroad, before they settle down. Later starts mean more couples need help conceiving, and in Kerala, many can afford it.

Three IVF chains have bought their way in since 2024. Birla Fertility & IVF acquired Kozhikode-based ARMC IVF in May 2024. In March this year, Nova IVF bought a majority stake in Craft Hospital, near Kochi. And now Indira IVF, India’s largest fertility chain, is negotiatingThe Economic TimesIndira IVF in talks to acquire Sabine in nearly Rs 1,300 crore deal to buy 70–75% of Sabine Hospital, the state’s biggest IVF provider, in a deal that would value it at up to Rs 1,300 crore.

They are buying because building doesn’t work. “It’s very tough to get into the Kerala market,” a sector executive said, recounting a conversation with the CEO of a south Indian IVF chain. “He said Kerala is a different ball game than Bengaluru or Hyderabad. Doctors act as a team. If you establish a centre from scratch, you will never get footfall.” In other words, patients in Kerala follow doctors they trust, not brands.

Of the three chains, Indira has the most riding on its deal.